Brii Biosciences expands focus to neurosciences

Drug Discovery |  News | 0 Comment | 04 Dec, 2019

Brii Biosciences, a clinical-stage company committed to serving patients’ needs and improving public health in China and around the world, has announced two leadership appointments th...Read more

Innovent, Eli Lilly presents co-developed cancer-fighting Tyvyt at CIIE 2019

Drug Discovery |  News | 0 Comment | 02 Dec, 2019

Innovent Biologics, a multinational biopharmaceutical company, and Eli Lilly and Company presented their co-developed Tyvyt® (generic name: sintilimab injection), a fully human anti-pro...Read more

Chugai Pharma's study on satralizumab published in The New England Journal of Medicine

Drug Discovery |  News | 0 Comment | 02 Dec, 2019

 Chugai Pharmaceutical has announced that the "New England Journal of Medicine" (NEJM) online edition November 27 Results of the global phase III SAkuraSky clinical study (NCT02028884)...Read more

Astellas to treat men with metastatic castration-resistant prostate cancer in China

Drug Discovery |  News | 0 Comment | 26 Nov, 2019

Astellas Pharma Inc.,  based in Tokyo, Japan has announced the China National Medical Products Administration (NMPA) approved a new drug application (NDA) for XTANDI® (en...Read more

Pfizer Unveils Positive Results for VIZIMPRO® as first-line monotherapy in NSCLC patients

Drug Discovery |  News | 0 Comment | 26 Nov, 2019

Pfizer Inc. on 25th Nov 2019, announced the efficacy and tolerability results from the subgroup analysis of Asian patients enrolled in the  ARCHER 1050, a randomized, multicenter, mult...Read more

Merck presented Data on Tepotinib for NSCLC at ESMO Asia 2019

Drug Discovery |  News | 0 Comment | 25 Nov, 2019

Merck, a leading science and technology company, on 25 Nov 2019, announced the presentation of multiple abstracts on tepotinib* at the European Society for Medical Oncology (ESMO) Asia Cong...Read more

BeiGene receives its first FDA approval

Drug Discovery |  News | 0 Comment | 18 Nov, 2019

BeiGene, Ltd., China, a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of c...Read more

Yuhan Pharmaceuticals partners with Cyclica

Drug Discovery |  News | 0 Comment | 13 Nov, 2019

South Korean healthcare company, Yuhan Pharmaceuticals (Yuhan) and Cyclica Inc. (Cyclica), a leading neo biotechnology company announce a collaboration to apply Cyclica’s proprietary ...Read more

China approves Alzheimer's drug

Drug Discovery |  News | 0 Comment | 11 Nov, 2019

The State Food and Drug Administration of China (CFDA) has conditionally approved the application for the listing of the Ganlut sodium capsule (trade name “Nine Phase One”)...Read more

Samsung Biologics collaborates with Ichnos Sciences in derma space

Drug Discovery |  News | 0 Comment | 06 Nov, 2019

South Korea headquartered Samsung Biologics has announced the signing of a long-term agreement with US based Ichnos Sciences for manufacturing drug substance for ISB 830, an anti-OX40 monoc...Read more

EU approves BAVENCIO® (avelumab) Plus Axitinib to treat RCC

Drug Discovery |  News | 0 Comment | 29 Oct, 2019

Merck and Pfizer Inc. on 29 Oct 2019, announced that the European Commission (EC) has approved BAVENCIO® (avelumab) in combination with axitinib for the first-line treatment of adu...Read more

Biogen plans regulatory filing for Aducanumab for Alzheimer's

Drug Discovery |  News | 0 Comment | 23 Oct, 2019

Biogen and Eisai, Co., Ltd. (Tokyo, Japan) has announced that, after consulting with the U.S. Food and Drug Administration (FDA), Biogen plans to pursue regulatory approval for aducanumab, ...Read more

Takeda acquires license for celiac disease therapy

Drug Discovery |  News | 0 Comment | 22 Oct, 2019

Japanese firm Takeda Pharmaceutical Company  and US based COUR Pharmaceutical Development Company, Inc. have announced that Takeda has acquired an exclusive global license to develop a...Read more

NeuClone announces First Human dose of Stelara® (Ustekinumab) Biosimilar candidate

Drug Discovery |  News | 0 Comment | 21 Oct, 2019

NeuClone, a clinical-stage biopharmaceutical company exclusively focused on developing high-quality biosimilar products, announced on 17 Oct 2019 that it has commenced dosing of Stelara®...Read more

Trastuzumab deruxtecan gets FDA priority review to treat metastatic breast cancer

Drug Discovery |  News | 0 Comment | 18 Oct, 2019

AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo) have announced that the US Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA...Read more

Lilly's Migraine drug receives FDA approval

Drug Discovery |  News | 0 Comment | 14 Oct, 2019

Eli Lilly and Company  has announced that the U.S. Food and Drug Administration (FDA) has approved REYVOW™ (lasmiditan) an oral medication for the acute treatment of mi...Read more

Gilead Sciences submits NDA to treat RA in Japan

Drug Discovery |  News | 0 Comment | 09 Oct, 2019

Gilead Sciences, Inc. has announced the New Drug Application (NDA) for filgotinib, an investigational, oral, selective JAK1 inhibitor for the treatment of adults with rheumatoid arthri...Read more

Bayer and RIKEN establish partnership for novel drug discovery

Drug Discovery |  News | 0 Comment | 09 Oct, 2019

Bayer AG (Bayer), and RIKEN Innovation Co., Ltd. (RIKEN Innovation), have entered into a strategic collaboration agreement to jointly explore novel drug discovery opportunities across indic...Read more